| Risk factors and biomarkers for immune-related adverse events: a practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors A Chennamadhavuni, L Abushahin, N Jin, CJ Presley, A Manne Frontiers in immunology 13, 779691, 2022 | 211 | 2022 |
| Association of broad-based genomic sequencing with survival among patients with advanced non–small cell lung cancer in the community oncology setting CJ Presley, D Tang, PR Soulos, AC Chiang, JA Longtine, KB Adelson, ... Jama 320 (5), 469-477, 2018 | 137 | 2018 |
| Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, ... JAMA oncology 7 (12), 1856-1861, 2021 | 124 | 2021 |
| Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trials JM O’Connor, KL Fessele, J Steiner, K Seidl-Rathkopf, KR Carson, ... JAMA oncology 4 (8), e180798-e180798, 2018 | 110 | 2018 |
| Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers M Li, D Spakowicz, J Burkart, S Patel, M Husain, K He, EM Bertino, ... Journal of cancer research and clinical oncology 145, 2541-2546, 2019 | 108 | 2019 |
| Treatment-related complications of systemic therapy and radiotherapy V Jairam, V Lee, HS Park, CR Thomas, ER Melnick, CP Gross, CJ Presley, ... JAMA oncology 5 (7), 1028-1035, 2019 | 106 | 2019 |
| Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers E Cheng, PR Soulos, ML Irwin, EMC Feliciano, CJ Presley, CS Fuchs, ... JAMA network open 4 (12), e2139593-e2139593, 2021 | 104 | 2021 |
| Patterns of use and short-term complications of breast brachytherapy in the national Medicare population from 2008–2009 CJ Presley, PR Soulos, J Herrin, KB Roberts, JB Yu, B Killelea, ... Journal of clinical oncology 30 (35), 4302-4307, 2012 | 85 | 2012 |
| Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting D Kilari, E Soto-Perez-de-Celis, SG Mohile, SMH Alibhai, CJ Presley, ... Journal of geriatric oncology 7 (4), 293-304, 2016 | 80 | 2016 |
| Analysis of patient preferences in lung cancer–estimating acceptable tradeoffs between treatment benefit and side effects EM Janssen, SM Dy, AS Meara, PJ Kneuertz, CJ Presley, JFP Bridges Patient preference and adherence, 927-937, 2020 | 73 | 2020 |
| Implementing a multidisciplinary approach for older adults with cancer: geriatric oncology in practice CJ Presley, JL Krok-Schoen, SA Wall, AM Noonan, DC Jones, E Folefac, ... Bmc Geriatrics 20, 1-9, 2020 | 62 | 2020 |
| Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications D Spakowicz, R Hoyd, M Muniak, M Husain, JS Bassett, L Wang, ... BMC cancer 20, 1-13, 2020 | 57 | 2020 |
| Gaps in nutritional research among older adults with cancer CJ Presley, E Dotan, E Soto-Perez-de-Celis, A Jatoi, SG Mohile, E Won, ... Journal of geriatric oncology 7 (4), 281-292, 2016 | 57 | 2016 |
| Immunotherapy in older adults with cancer CJ Presley, F Gomes, CE Burd, R Kanesvaran, ML Wong Journal of Clinical Oncology 39 (19), 2115, 2021 | 54 | 2021 |
| Bone metastases, skeletal-related events, and survival in patients with metastatic non–small cell lung cancer treated with immune checkpoint inhibitors A Qin, S Zhao, A Miah, L Wei, S Patel, A Johns, M Grogan, EM Bertino, ... Journal of the National Comprehensive Cancer Network 19 (8), 915-921, 2021 | 48 | 2021 |
| Information needs of older women with early-stage breast cancer when making radiation therapy decisions SY Wang, G Kelly, C Gross, BK Killelea, S Mougalian, C Presley, ... International Journal of Radiation Oncology* Biology* Physics 98 (4), 733-740, 2017 | 47 | 2017 |
| A new approach to understanding racial disparities in prostate cancer treatment CJ Presley, AC Raldow, LD Cramer, PR Soulos, JB Long, BY James, ... Journal of geriatric oncology 4 (1), 1-8, 2013 | 46 | 2013 |
| Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptoms BL Andersen, TR Valentine, SB Lo, DP Carbone, CJ Presley, PG Shields Lung Cancer 145, 195-204, 2020 | 44 | 2020 |
| Association between age and survival trends in advanced non–small cell lung cancer after adoption of immunotherapy T Voruganti, PR Soulos, R Mamtani, CJ Presley, CP Gross JAMA oncology 9 (3), 334-341, 2023 | 39 | 2023 |
| Caring for the older population with advanced lung cancer CJ Presley, CH Reynolds, CJ Langer American Society of Clinical Oncology Educational Book 37, 587-596, 2017 | 39 | 2017 |